The Journal of Haemophilia Practice
Launched in 2014, The Journal of Haemophilia Practice is an international, open-access, peer-reviewed journal that aims to provide a forum for all members of the multidisciplinary bleeding disorders care team and covers all aspects of bleeding disorders care and practice.
It is now widely recognised that the care and management of people with haemophilia and other rare bleeding disorders should always be based on a multidisciplinary approach, with value placed on the specific expertise brought by allied health care professionals, including nurses, physiotherapists, data managers, social workers, and psychologists. We believe that sharing experience on evidence-based care helps to promote expertise and benefits patients.
The Journal of Haemophilia Practice accepts original research, case reports, case series, methodology papers, clinical updates, reviews, qualitative research and opinion pieces, as well as outcomes research written by and/or with individuals affected by bleeding disorders.
“Many nurses and allied health professionals now study beyond degree level and are undertaking qualitative research as part of masters and doctoral level study. Supporting publication of their work enhances the care that is provided to people with bleeding disorders through shared patient experience and outcome.”
Kate Khair, Editor-in-Chief, The Journal of Haemophilia Practice
Publication is continuous, throughout the year. Articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs license (CC- BY-NC-ND 3.0).
Editor-in-Chief: Kate Khair
Managing Editor: Mike Holland
Technical Editor: Kathryn Jenner
Enquiries should be addressed to Mike Holland: firstname.lastname@example.org
Alongside experts in bleeding disorders care from around the world, our editorial board includes members of the international bleeding disorders community who work in academia and patient advocacy.
Haemnet Ltd seeks to cover the publishing costs of The Journal of Haemophilia Practice through:
- Journal sponsorship funding received from pharmaceutical industry clients. The journal is currently sponsored by BioMarin.
- Article processing charges and publication fees charged for articles commissioned and funded by a pharmaceutical company or agency working on behalf of a pharmaceutical company
- Fees charged by Haemnet Ltd for specialist writing and editing services